Amoxiclav, powder for suspension 125mg+31.25mg/5ml 100ml

Composition

5 ml of the finished suspension contains amoxicillin (in the form of trihydrate) 125 mg and clavulanic acid (in the form of potassium salt) 31.25 mg;

excipients:

citric acid anhydrous,

sodium citrate anhydrous,

sodium benzoate,

microcrystalline cellulose,

sodium salt of carboxymethylcellulose,

xanthan gum,

colloidal silicon dioxide,

silicon dioxide,

sodium saccharin,

mannitol,

flavorings.

Pharmacological action

Broad-spectrum antibiotic; contains semi-synthetic penicillin amoxicillin and beta-lactamase inhibitor clavulanic acid.

Clavulanic acid provides a stable inactivated complex with these enzymes and ensures the resistance of amoxicillin to the effects of beta-lactamases produced by microorganisms.

Clavulanic acid, similar in structure to beta-lactam antibiotics, has a weak intrinsic antibacterial activity.

Amoxiclav has a wide spectrum of antibacterial action. Active against amoxicillin-sensitive strains, including beta-lactamase-producing strains, including aerobic gram-positive bacteria:  Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus viridans, Streptococcus bovis, Enterococcus spp., Staphylococcus aureus (except methicillin-resistant strains), Staphylococcus epidermidis (except methicillin-resistant strains), Staphylococcus saprophyticus, Listeria spp. ;aerobic gram-negative bacteria:  Bordetella pertussis, Brucella spp., Campylobacter jejuni, Escherichia coli, Gardnerella vaginalis, Haemophilus ducreyi, Haemophilus influenzae, Helicobacter pylori, Klebsiella spp., Moraxella catarrhalis, Neisseria gonorrhoeae, Neisseria meningitidis, Pasteurella multocida, Proteus spp., Salmonella spp., Shigella spp., Vibrio cholerae, Yersinia enterocolitica, Eikenella corrodens; gram-positive Anaerobes:  Peptococcus spp., Peptostreptococcus spp., Clostridium spp., Actinomyces israelii, Fusobacterium spp., Prevotella spp., Gram-negative Anaerobes:  Bacteroides spp.

Indications

• pneumonia,
• urinary tract
• infections, skin and soft tissue
• infections, blood poisoning, peritonitis, bone and joint infections, inflammation of the appendages.

Contraindications

Hypersensitivity to Amoxiclav.

Side effects

• nausea,
• vomiting,
• diarrhea (diarrhea)
• redness of the skin,
• rash.

Interaction

When used simultaneously Amoxiclav and indirect anticoagulants show an increase in prothrombin time. Therefore, this combination is prescribed with caution.

Concomitant use of Amoxiclav with allopurinol increases the risk of side effects such as exanthema.

When used concomitantly, Amoxiclav increases the toxicity of methotrexate. The combination of Amoxicillin with rifampicin is antagonistic (there is a mutual weakening of the antibacterial effect).

Amoxiclav should not be used simultaneously with bacteriostatic antibiotics (macrolides, tetracyclines), sulfonamides due to the possible decrease in the effectiveness of Amoxiclav. When used concomitantly, Amoxiclav reduces the effectiveness of oral contraceptives.

How to take, course of use and dosage

Amoxiclav: adults and children over 14 years of age on 1 tab. (375 mg) 3 times / day. For severe infections,1 tablet (625 mg) 3 times / day.

Children from 7 to 14 years of age: 2 teaspoons (10 ml) of suspension 3 times / day. Children from 1 to 7 years of age: 1 teaspoon of suspension 3 times a day.

Children under 1 year of age: 0.75-1.25 ml of drops or 1/2 teaspoon of suspension 3 times / day. The course of treatment with Amoxiclav is 5-14 days.

Overdose

There are no reports of overdose.

Symptoms: abdominal pain, diarrhea, vomiting; possibly also agitation, insomnia, dizziness; in some cases – convulsions.

Treatment: in case of recent use of the drug (less than 4 hours), gastric lavage should be performed and activated charcoal should be prescribed to reduce the absorption of the drug; if necessary, symptomatic therapy should be performed. Hemodialysis is effective.

Special instructions

Caution should be exercised when prescribing Amoxiclav to patients prone to allergic reactions, as well as to patients with known hypersensitivity to cephalosporin antibiotics, as there is a risk of developing cross-sensitivity.

Simultaneous use with drugs to reduce blood clotting leads to an increase in the effect of the latter. The drug weakens the effect of aminoglycoside antibiotics. With long-term treatment, it is necessary to monitor the state of function of the hematopoietic organs, liver and kidneys.

Form of production

Powder for the preparation of a suspension for oral use

Storage conditions

Store in a dry place, out of reach of children, at a temperature not exceeding 25°C. After preparation, the oral suspension should be stored at a temperature of 2°to 8°C in a tightly closed bottle and used for 7 days.

Shelf life

2 years

Active ingredient

Amoxicillin, Clavulanic Acid

Conditions of release from pharmacies

By prescription

Dosage form

suspension for oral use

Description

Children older than 3 months, Children as prescribed by a doctor

Indications

Urinary Tract Infections, Tonsillitis, Sinusitis, Pneumonia, Osteomyelitis, Cholecystitis, Periodontitis, Sore Throat, Bronchitis, Skin Infections, Otitis Media, Pharyngitis